Clínica de Marly S.A. (BVC: MARLY)

Clínica de Marly Income Statement

Financials in millions COP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	383,844	362,905	321,343	278,599	209,776	249,445
Revenue Growth (YoY)	12.52%	12.93%	15.34%	32.81%	-15.90%	30.43%
Cost of Revenue	243,614	231,992	208,407	178,364	144,716	159,630
Gross Profit	140,230	130,913	112,935	100,234	65,060	89,815
Selling, General & Admin	38,446	36,964	33,870	28,018	26,881	25,229
Other Operating Expenses	5,726	5,453	3,985	3,091	2,401	1,938
Operating Expenses	48,931	47,948	43,641	36,557	35,008	33,058
Operating Income	91,300	82,965	69,294	63,678	30,052	56,757
Interest Expense	-1,770	-2,324	-2,206	-1,608	-2,605	-3,807
Interest & Investment Income	14,292	12,491	5,805	1,749	3,697	2,128
Earnings From Equity Investments	20,840	21,135	19,381	18,419	4,091	8,320
Currency Exchange Gain (Loss)	-87.68	-3,530	2,616	2,421	133.45	49.17
Other Non Operating Income (Expenses)	-6,738	-8,019	-12,403	-12,456	5,858	788.86
EBT Excluding Unusual Items	117,835	102,718	82,487	72,203	41,227	64,235
Gain (Loss) on Sale of Investments	94.87	-	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	26.91	23.36	210.46
Asset Writedown	-10,133	-7,413	-550.3	-1,958	-1,134	-5,924
Pretax Income	107,797	95,306	81,936	70,271	40,117	58,522
Income Tax Expense	34,313	30,536	26,642	20,467	12,280	20,513
Earnings From Continuing Operations	73,484	64,770	55,295	49,804	27,836	38,009
Minority Interest in Earnings	-523.93	-89.46	-713.74	-830.06	-385.4	-473.24
Net Income	72,960	64,681	54,581	48,974	27,451	37,536
Net Income to Common	72,960	64,681	54,581	48,974	27,451	37,536
Net Income Growth	20.08%	18.50%	11.45%	78.41%	-26.87%	64.07%
Shares Outstanding (Basic)	-	11	11	11	11	11
Shares Outstanding (Diluted)	-	11	11	11	11	11
EPS (Basic)	-	6057.41	5111.57	4586.50	2570.82	3515.25
EPS (Diluted)	-	6057.41	5111.57	4586.50	2570.82	3515.25
EPS Growth	-	18.50%	11.45%	78.41%	-26.87%	64.07%
Free Cash Flow	7,651	23,300	27,495	16,504	22,531	-15,760
Free Cash Flow Per Share	-	2182.04	2574.90	1545.65	2110.04	-1475.97
Dividend Per Share	1200.000	1200.000	696.000	564.000	-	-
Dividend Growth	72.41%	72.41%	23.40%	-	-	-
Gross Margin	36.53%	36.07%	35.14%	35.98%	31.01%	36.01%
Operating Margin	23.79%	22.86%	21.56%	22.86%	14.33%	22.75%
Profit Margin	19.01%	17.82%	16.99%	17.58%	13.09%	15.05%
Free Cash Flow Margin	1.99%	6.42%	8.56%	5.92%	10.74%	-6.32%
EBITDA	96,004	88,446	75,033	69,075	35,727	62,649
EBITDA Margin	25.01%	24.37%	23.35%	24.79%	17.03%	25.12%
D&A For EBITDA	4,704	5,480	5,739	5,397	5,674	5,892
EBIT	91,300	82,965	69,294	63,678	30,052	56,757
EBIT Margin	23.79%	22.86%	21.56%	22.86%	14.33%	22.75%
Effective Tax Rate	31.83%	32.04%	32.51%	29.13%	30.61%	35.05%

Source: S&P Capital IQ. Standard template. Financial Sources.